The S&P/ASX200 closed up Monday, gaining 47 points or 0.6% to 7,371.

Now.

How many times have you heard CSL described as the best company Australia has ever produced (and how many times have you wished you were in the IPO at 76 cents a share?) We can't promise we've found the next CSL, but our next event will give you the insights you need to invest in the biotech sector. We've lined up some true experts in the field to share how they value biotech companies and their expectations for how and when shareholders will see returns.

"Biotech Unlocked" is on this Thursday from 9am (AEDT) including a showcase of some of the most exciting ASX-listed biotech companies.

Three top VODs

Four for the week: Carl's favourite stocks

Three commodity stocks for value investors...

Transitory is over

Hosted on Acast. See acast.com/privacy for more information.